Novo Nordisk A S Ratios (2012-2014) | NVO

Ratios Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014
Profitability
Gross Margin 80.82%82.42%82.47%84.95%81.93%83.14%82.82%84.30%82.94%83.04%84.63%83.73%
EBT Margin 34.13%35.66%37.13%35.57%38.87%40.62%40.43%36.00%40.81%41.56%37.93%33.62%
EBIT Margin 35.99%39.32%39.68%36.14%37.86%40.14%38.98%34.00%39.48%40.40%38.46%37.12%
EBITDA Margin 35.99%39.32%39.68%36.14%37.86%40.14%38.98%34.00%39.48%40.40%38.46%37.12%
Operating Margin 35.99%39.32%39.68%36.14%37.86%40.14%38.98%34.00%39.48%40.40%38.46%37.12%
Net Margin 34.13%35.66%37.13%35.57%38.87%40.62%40.43%36.00%40.81%41.56%37.93%33.62%
FCF Margin 31.48%36.79%40.25%7.42%35.37%34.06%30.33%24.96%20.01%37.56%55.37%29.23%
Efficiency
Assets Average 10.66B10.94B38.61B38.18B10.99B11.81B41.34B41.01B11.67B11.86B44.56B
Asset Utilization Ratio 0.350.361.301.230.360.371.311.320.35
Leverage & Solvency
Interest Coverage Ratio 17.068.8718.9154.8370.4732.0271.0043.3225.4161.7719.27-24.41
Times Interest Earned 17.068.8718.9154.8370.4732.0271.0043.3225.4161.7719.27-24.41
Valuation
Enterprise Value 80.45B90.25B91.53B94.66B90.44B86.78B94.76B103.47B125.54B127.02B130.96B116.38B
Market Capitalization 80.45B90.25B91.53B94.66B90.44B86.78B94.76B103.47B125.54B127.02B130.96B116.38B
Return Ratios
Return on Sales 0.36%0.37%0.38%0.39%0.39%0.39%0.40%0.39%0.38%
Return on Assets 0.12%0.13%0.49%0.48%0.14%0.14%0.52%0.51%0.14%